By Britain Eakin ( December 2, 2021, 8:12 PM EST) -- The Patent Trial and Appeal Board has ruled against SNIPR Biome in an interference proceeding after determining that The Rockefeller University was first to invent using the gene-editing technology CRISPR to kill specific bacteria, canceling five SNIPR patents as a result....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.